HOME >> BIOLOGY >> NEWS
Discovery Could Help Understand Breast-Cancer Therapies

CHAMPAIGN, Ill. -- Breast-cancer researchers at the University of Illinois have identified four amino acids viewed as leading actors in the binding of estrogen and anti-estrogen hormones to receptor proteins in the female reproductive system.

The findings could prove to be crucial in efforts to understand how the receptors respond to drug therapies and how they become resistant to tamoxifen, which, for 20 years, has been the anti-estrogen agent most commonly used against breast cancer in the United States, said lead researcher Benita Katzenellenbogen, a professor of molecular and integrative physiology.

The research was published in the Aug. 16 issue of The Journal of Biological Chemistry. The authors were Katzenellenbogen, who on Oct. 18 will receive the 1996 Komen Scientific Distinction Award from the Susan G. Komen Breast Cancer Foundation in Dallas; her husband, John Katzenellenbogen, professor of chemistry; Kirk Ekena, postdoctoral researcher; and Karen E. Weis, research associate.

The estrogen receptor is a protein containing about 600 amino acids. It takes in estrogen, providing the transcription signal (the message system) for biological activity important in bone maintenance, especially for postmenopausal women, and for cardiovascular protection. But estrogen also increases the risk of breast cancer in some women.

"We've identified portions of the hormone-binding domain of this protein that appear to be critical sites for binding with the hormone," Benita Katzenellenbogen said. "We've shown that if one alters one of these four amino acids then one eliminates the ability of estrogen to bind, and as a consequence one also eliminates the ability of these receptors to act as transcriptional regulators."

The research, funded by the National Institutes of Health, was conducted using a molecular biological technique called alanine-scanning mutagenesis, in which a different form of amino acid is substituted one at a
'"/>

Contact: Jim E. Barlow, Life Sciences Editor
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
3-Oct-1996


Page: 1 2

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could improve anemia treatment in patients
9. Discovery could lead to better treatment for cryptosporidum infections
10. Discovery of brain disorder gene paves way for genetic test
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Discovery Could Help Understand Breast Cancer Therapies

(Date:6/17/2013)... State University research associate has received a prestigious fellowship ... prevent the spread of malaria. , Bart Bryant, research ... Health,s National Research Service Award Individual Postdoctoral Fellowship, which ... Kansas State University researcher to receive the award and ... such an award. , Bryant, a university doctoral graduate ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
(Date:6/15/2013)... -- A drug approved in Europe to treat osteoporosis ... breast cancer cells, even in cancers that have become ... Cancer Institute study. , The findings, presented June 15, ... Francisco, indicate that the drug bazedoxifene packs a powerful ... breast cancer cell growth, but also flags the estrogen ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 This ... of pharmaceutical advertising and promotion, and review the ... will learn how to apply these principles through ... ,     The fundamentals on FDA regulations ... promotional labeling ,     Assessing traditional and newer ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics [Diabetes & Oncology] ... to their offering.      (Logo: ...
(Date:6/18/2013)... June 18, 2013 As a ... Inc proudly announces the release of their infographic ... Fitness ". , MeMD's goal was to leverage ... of Health 2.0, Health 3.0 and mHealth.The infographic ... transform medical care and the fitness industry in ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
Cached News: